Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:00 AM
Ignite Modification Date:
2025-12-26 @ 11:00 AM
NCT ID:
NCT05702606
Eligibility Criteria:
Inclusion Criteria:
* Patients with CP.
* With a CP classified as spastic.
* Spasticity in the Triceps Surae muscle.
* Who have a Gross Motor Classification (GMFCS) level between l and ll
* Having signed the informed consent by the participant or your legal guardian
Exclusion Criteria:
* Have received treatment with shock waves in the Triceps Surae or any other muscle of the lower extremity in the 6 months before the study.
* Have received treatment with botulinum toxin and/or treatment focal intramuscular injection with phenol or alcohol in the Triceps Surae or some other lower extremity muscle in the 6 months before the study.
* Patients who have undergone surgery for deformities foot orthotics in the last year.
* Fixed deformities in the ankle joint.
* Clinical signs of myopathy and neuropathy.
* Infection or tumor at the site of application of the therapy\*.
* Severe blood dyscrasia\*.
* Blood coagulation disorders\*.
* Treatment with oral anticoagulants\*
* Contraindications of radial extracorporeal shock wave therapy.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
4 Years
Maximum Age:
50 Years
Study:
NCT05702606
Study Brief:
Protocol Section:
NCT05702606